LS60 Stock Overview
Engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Clinical Laserthermia Systems AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 0.48 |
52 Week High | SEK 7.80 |
52 Week Low | SEK 0.04 |
Beta | 0.35 |
11 Month Change | -73.32% |
3 Month Change | -0.65% |
1 Year Change | 70.32% |
33 Year Change | -99.17% |
5 Year Change | -99.78% |
Change since IPO | -99.70% |
Recent News & Updates
Recent updates
Shareholder Returns
LS60 | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | -2.7% | 3.7% | 0.09% |
1Y | 70.3% | 4.1% | 3.1% |
Return vs Industry: LS60 exceeded the German Medical Equipment industry which returned 4.1% over the past year.
Return vs Market: LS60 exceeded the German Market which returned 3.1% over the past year.
Price Volatility
LS60 volatility | |
---|---|
LS60 Average Weekly Movement | 225.6% |
Medical Equipment Industry Average Movement | 4.5% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.7% |
10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: LS60's share price has been volatile over the past 3 months.
Volatility Over Time: LS60's weekly volatility has decreased from 1648% to 226% over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | 17 | Dan Mogren | www.clinicallaser.se |
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment.
Clinical Laserthermia Systems AB (publ) Fundamentals Summary
LS60 fundamental statistics | |
---|---|
Market cap | €4.14m |
Earnings (TTM) | -€6.25m |
Revenue (TTM) | €953.68k |
4.3x
P/S Ratio-0.7x
P/E RatioIs LS60 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
LS60 income statement (TTM) | |
---|---|
Revenue | SEK 10.83m |
Cost of Revenue | SEK 8.46m |
Gross Profit | SEK 2.37m |
Other Expenses | SEK 73.27m |
Earnings | -SEK 70.90m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 23, 2024
Earnings per share (EPS) | -9.03 |
Gross Margin | 21.88% |
Net Profit Margin | -654.91% |
Debt/Equity Ratio | 3.0% |
How did LS60 perform over the long term?
See historical performance and comparison